Dyskeratosis congenita (DC) is a rare inherited disorder caused by defective maintenance of telomeres, the protective caps on the ends of chromosomes. It affects multiple organ systems, most seriously the bone marrow, lungs, and liver, and it significantly raises the risk of cancer. The condition is sometimes called Zinsser-Engman-Cole syndrome, and it falls under a broader category known as telomere biology disorders.
The Classic Triad of Symptoms
DC is traditionally recognized by three hallmark features that often appear during childhood or adolescence: abnormal skin pigmentation, nail changes, and white patches inside the mouth.
The skin changes appear as a lace-like pattern of darkened spots, most commonly on the face, upper chest, and upper arms. These darker patches are often surrounded by lighter spots, tiny visible blood vessels, and thin, fragile-looking skin. Nail dystrophy typically shows up as thin, ridged nails that may eventually develop a wing-shaped overgrowth of skin at the base. The white patches in the mouth, called oral leukoplakia, most often appear on the tongue and are considered a precancerous condition.
Not every person with DC develops all three features, and many patients are first identified through blood problems rather than these visible signs.
Why Telomeres Matter
Your chromosomes have repeating sequences of DNA at their tips that act like the plastic caps on shoelaces. These telomeres shorten slightly every time a cell divides. When they get critically short, the cell either dies or stops dividing entirely. This is a normal part of aging, but in DC it happens far too quickly.
At least 15 genes have been linked to DC, all involved in building or maintaining telomeres. Mutations in any of these genes accelerate telomere shortening, which is why DC hits tissues that depend on rapid cell turnover the hardest: blood-forming cells in the bone marrow, the lining of the mouth and gut, skin, and the lungs.
How DC Is Inherited
DC follows several different inheritance patterns depending on the gene involved. The X-linked form, caused by mutations in the DKC1 gene, predominantly affects males because they carry only one X chromosome. A single faulty copy is enough to cause disease. Females with one affected copy are usually carriers without symptoms.
Other genetic forms follow autosomal dominant inheritance, where one mutated copy from either parent causes disease, or autosomal recessive inheritance, where both parents must pass along a defective copy. Because so many different genes can be responsible, families with DC can look very different from one another in terms of severity and age of onset.
Bone Marrow Failure
The most dangerous complication of DC is bone marrow failure, where the marrow gradually loses its ability to produce enough red blood cells, white blood cells, and platelets. In one study of children diagnosed with DC, 92% progressed to moderate or severe bone marrow failure at a median age of 7 years. Bone marrow failure accounts for 60 to 70% of deaths in DC patients, making it the leading cause of mortality.
Early signs often include easy bruising, unusual fatigue, and frequent infections. Blood counts typically decline gradually rather than all at once, which means regular monitoring is essential for catching the problem before it becomes life-threatening.
Cancer Risk
People with DC face a dramatically elevated cancer risk. The cumulative incidence of cancer reached 53% by age 44 in one National Cancer Institute cohort. Head and neck squamous cell carcinomas are the most common solid tumors, accounting for about 40% of cancers in DC patients. Tongue cancer risk is roughly 1,150 times higher than in the general population, likely connected to the oral leukoplakia that many patients develop. Acute myeloid leukemia risk is approximately 195 times the expected rate.
Skin cancer and anorectal cancer are the next most frequent solid tumors. The precancerous oral patches, combined with the underlying telomere dysfunction that destabilizes DNA, create an environment where malignancies develop earlier and more often than they would otherwise.
Lung and Liver Complications
Pulmonary fibrosis, a progressive scarring of the lungs, is the second leading cause of death in DC, responsible for roughly 15% of mortality. The lungs gradually lose their ability to exchange oxygen efficiently, leading to worsening shortness of breath over time. This complication can appear even in patients whose blood counts remain relatively stable.
Liver involvement, including enlargement, iron overload, scarring, and cirrhosis, has been reported in about 10% of cases. When cirrhosis progresses far enough, liver transplantation may become necessary, though outcomes in DC patients are complicated by the underlying telomere dysfunction affecting healing and blood counts.
Severe Variants in Young Children
Two particularly severe forms of DC appear in infancy or early childhood. Hoyeraal-Hreidarsson syndrome is defined by underdevelopment of the cerebellum (the brain region controlling coordination and balance), along with immune deficiency, progressive bone marrow failure, and restricted growth before birth. Nearly all affected children show small head size and developmental delays. Some also develop seizures or abnormal brain structure. The median survival for Hoyeraal-Hreidarsson syndrome is just 5 years.
Revesz syndrome is another severe childhood variant that includes eye abnormalities alongside the other features. No patients with either severe form have been reported to survive past age 20.
How DC Is Diagnosed
The key diagnostic test measures telomere length in white blood cells using a technique called flow-FISH. Telomere lengths below the first percentile for the patient’s age are highly sensitive and specific for DC. Lymphocyte telomere measurement alone has a positive predictive value of 85%, making it the single most useful screening test. Genetic testing can then identify the specific gene mutation, which helps predict disease severity and inheritance pattern.
Diagnosis can be tricky in patients who lack the classic skin, nail, and mouth features. Some people are identified only after unexplained bone marrow failure or pulmonary fibrosis prompts telomere testing.
Treatment and Management
There is no cure for DC, but several treatments can manage its most serious complications. For bone marrow failure, a stem cell transplant (using donor blood-forming cells) is the only option that can restore normal blood production. This is typically considered when patients develop severe low blood counts, a precancerous bone marrow condition called myelodysplastic syndrome, or leukemia.
Androgen therapy, using synthetic hormones that stimulate red blood cell production, can improve blood counts in some patients and may delay the need for transplant. Growth factors that boost white blood cell production are sometimes used alongside androgens to reduce infection risk.
Because DC affects so many organ systems, patients generally need coordinated monitoring: regular blood counts, lung function tests, liver evaluations, dental exams for oral changes, and cancer screening starting earlier than usual. The median survival for patients with classic DC (excluding the severe childhood variants) is around 44 years, though this varies widely depending on the genetic mutation, the severity of bone marrow failure, and how early complications are detected.